Pfizer sees 24% of eligible Americans getting COVID-19 boosters
David Ryder/Getty Images News
Pfizer expects roughly 24% of the US population that is eligible to receive updated COVID-19 vaccinations will actually get the shot, amounting to around 82M people, according to reports.
Pfizer CFO David Denton delivered the estimate at the JP Morgan US All Stars Conference. Moderna has said that it expects between 50M and 100M doses of the vaccine to be administered this year, according to Reuters.
Updated vaccines by Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) were authorized and approved by the FDA last week. The CDC has recommended that everyone six months or older get the updated vaccine if they havenât gotten a booster recently.
The FDA is also in the process of reviewing an updated vaccine by Novavax (NASDAQ:NVAX).
Only around 17% of eligible Americans have received COVID-19 booster shots of the vaccine that was released last fall, according to Bloomberg.
Denton also told listeners that demand for Pfizer's COVID-19 treatment Paxlovid was largely in step with the increased rate of infection. He added that the government-purchased inventory of the medicine will have to be worked through first before the product can be launched commercially, with 2023 considered a transition year, Bloomberg added.
More on COVID-19 vaccines:
The 'tripledemic' threat to be less severe this season
FDA green lights Moderna, Pfizer updated COVID-19 vaccines
CDC recommends COVID-19 shots for people age six months and older (update)
Novavax updated COVID vaccine ready for US distribution
Vaccine makers light up as COVID hospitalizations rise